Tue, 01 Nov 2016 07:28:23 GMT
Summary of Analyst's Beliefs: Eli Lilly and Company (NYSE:LLY)
- Is stories
10/31/2016, Eli Lilly and Company
(NYSE:LLY) stock dropped -0.93% or -0.69 points. After the session opened at $74.63, the stock's price hit the top of $ 74.74 while it touched a low of $ 73.80. Total 3.56 million shares changed on hands and it kept ...
Tue, 01 Nov 2016 07:09:15 GMT
Tue, 01 Nov 2016 00:57:43 GMT
Brokers Issue Forecasts for Eli Lilly and Co.'s FY2017 Earnings (LLY)
- Cosumnes Connection (subscription)
According to a research note published on Nov 13, 2015, analysts at BMO Capital Markets have upped their rating on the company stock from Market Perform to Outperform. Eli Lilly and Company
Drug Manufacturers - Major holds an EPS of 2.32 that ...
Tue, 01 Nov 2016 00:55:54 GMT
Tue, 01 Nov 2016 00:01:35 GMT
Mon, 31 Oct 2016 20:04:44 GMT
Amgen, Gilead, Eli Lilly Eat Into AbbVie's Humira Sales: Analyst
- Investor's Business DailyEli Lilly
(LLY), Pfizer (PFE) and Gilead Sciences (GILD) are chipping away at AbbVie's (ABBV) Humira sales, Credit Suisse analyst Vamil Divan said Monday after AbbVie missed Q3 expectations Friday, primarily on declining Humira sales. Divan downgraded ...
Mon, 31 Oct 2016 17:21:15 GMT
Mon, 31 Oct 2016 16:56:46 GMT
Eli Lilly and's (LLY) "Buy" Rating Reaffirmed at Jefferies Group
- The Cerbat GemEli Lilly and Co
. logo Jefferies Group reiterated their buy rating on shares of Eli Lilly and Co
. (NYSE:LLY) in a report published on Friday morning. They currently have a $100.00 price objective on the stock, down from their previous price objective ...
Mon, 31 Oct 2016 15:52:06 GMT
Mon, 31 Oct 2016 15:42:35 GMT
Featured Stock to See: Eli Lilly and Company (NYSE:LLY)
The Stock had a 1.67 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1.77 and 1.92 respectively. Eli Lilly and Company
on 9/30/2016 reported its EPS as $0.88 with the analysts ...